Pharmacological inhibition of β-catenin/BCL9 interaction overcomes resistance to immune checkpoint blockades by modulating T(reg) cells

The Wnt/β-catenin (β-cat) pathway plays a critical role in cancer. Using hydrocarbon-stapled peptide technologies, we aim to develop potent, selective inhibitors targeting this pathway by disrupting the interaction of β-cat with its coactivators B-cell lymphoma 9 (BCL9) and B-cell lymphoma 9-like (B...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, M., Jin, J. Q., Xia, L., Xiao, T., Mei, S., Wang, X., Huang, X., Chen, J., Liu, M., Chen, C., Rafi, S., Zhu, A. X., Feng, Y.-X., Zhu, D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2019
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6506245/
https://www.ncbi.nlm.nih.gov/pubmed/31086813
http://dx.doi.org/10.1126/sciadv.aau5240

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6506245/
https://www.ncbi.nlm.nih.gov/pubmed/31086813
http://dx.doi.org/10.1126/sciadv.aau5240

Ejemplares similares